Odyssey Health (ODYY) Cash from Financing Activities (2014 - 2026)
Odyssey Health (ODYY) posted quarterly Cash from Financing Activities of $875000.0 for Q1 2026, up 201.2% quarter-over-quarter from $290500.0 in Q4 2025.
Odyssey Health (ODYY) Cash from Financing Activities (2014 - 2026) Analysis & Trends
Odyssey Health's Cash from Financing Activities history runs 13 years deep, the most recent figure standing at $875000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities changed N/A year-over-year to $875000.0; the TTM figure through Apr 2026 stood at $1.2 million (up 286.6% YoY), while the FY2025 annual figure was $294310.0, up 62.85% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $875000.0, up from $290500.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $1.1 million in Q2 2022, with the low at -$860659.0 in Q3 2022.
- The 5-year median for Cash from Financing Activities is $189212.0 (2023), against an average of $247067.4.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities surged 611.35% in 2023, then tumbled 113.97% in 2024.
- Odyssey Health's Cash from Financing Activities stood at $270710.0 in 2022, then fell by 18.39% to $220924.0 in 2023, then surged by 35.79% to $300000.0 in 2024, then fell by 3.17% to $290500.0 in 2025, then soared by 201.2% to $875000.0 in 2026.
- Business Quant data shows ODYY's Cash from Financing Activities at $875000.0 in Q1 2026, $290500.0 in Q4 2025, and -$5690.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Odyssey Health | 1.07 Mn | 771,705.04 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 875,000.00 |
| Jan 31, 2026 | 875,000.00 |
| Oct 31, 2025 | 290,500.00 |
| Oct 31, 2025 | 290,500.00 |
| Jul 31, 2025 | -5,690.00 |
| Jul 31, 2025 | -5,690.00 |
| Oct 31, 2024 | 300,000.00 |
| Oct 31, 2024 | 300,000.00 |
| Apr 30, 2024 | 84,007.00 |
| Apr 30, 2024 | 84,007.00 |
| Jan 31, 2024 | -124,207.00 |
| Jan 31, 2024 | -124,207.00 |
| Oct 31, 2023 | 220,924.00 |
| Oct 31, 2023 | 220,924.00 |
| Jul 31, 2023 | 157,500.00 |
| Jul 31, 2023 | 157,500.00 |
| Apr 30, 2023 | 131,690.00 |
| Apr 30, 2023 | 131,690.00 |
| Jan 31, 2023 | 889,188.00 |
| Jan 31, 2023 | 889,188.00 |